We are proud to present the new Rare Impact website. The Rare Impact collaboration group is chaired by Eurordis, and coordinated by Dolon.

This site features responsive design across all devices and screen sizes, and a really nice layered animated menu. Initially conceived as a very basic site by the client, it has been developed from a holding page, through an interim site, and now into the current site with a full CMS for autonomous management of the patient access reports. The CMS supports document management as well as responsive tables with ratings and harvey balls.

“After more than two years developing reports on patient access to ATMPs for 10 countries, we are delighted to say these reports are now available at rareimpact.eu. This was a really important output for this project as we want these reports to be the basis for discussion between payers, policymakers, patient associations and industry to help move the dial for patient access to advanced therapy medicinal products (ATMPs).” Darren Callanan, Dolon

You can find the site here: rareimpact.eu.